Children and young people’s cancers become focus of pioneering research in Southampton
Date:
Children and young people diagnosed with aggressive cancers could benefit from a pioneering project supported by Southampton researchers to create new treatments.
Scientists, Dr Ali Roghanian and Dr Salah Mansour from the University of Southampton, in partnership with teams at MiNK Therapeutics have been selected to develop an immunotherapy treatment that could target paediatric cancers such as bone sarcomas, acute myeloid leukaemia (AML) and medulloblastoma – a type of brain tumour.
Read the full article here.
